Key result
Severe maternal pulmonary arterial hypertension was associated with a markedly increased risk of preterm delivery (<37 weeks) compared to no PAH.
Why the study?
As more women with PAH choose pregnancy, newborn outcomes have become a priority, prompting the comparison of neonatal outcomes in pregnant women with heart disease-associated PAH.
Does the presence and severity of pulmonary arterial hypertension in pregnant women with heart disease increase the risk of adverse neonatal outcomes?
Cohort (n=127)
No
Does the presence and severity of pulmonary arterial hypertension in pregnant women with heart disease increase the risk of adverse neonatal outcomes?
Answers are grounded in this paper and cite their sources.
Severe pulmonary arterial hypertension in pregnant women with heart disease significantly increases the risk of adverse neonatal events, including preterm delivery, low birth weight, and NRDS, highlighting the need for multidisciplinary management.
BACKGROUND: As an increasing number of women with pulmonary arterial hypertension (PAH) choose to become pregnant, outcomes in newborns have become a priority. The main purpose of this study was to compare the neonatal outcomes in pregnant women with PAH associated with heart disease. METHODS: A single-center retrospective study was performed. Pregnancy with heart disease is divided into three groups: no PAH, mild PAH and severe PAH. Neonatal outcomes of pregnant women were compared among groups. Meanwhile, multivariable analyses were used to investigate the association between maternal PAH and adverse neonatal events. RESULTS: A total of 127 pregnant women with heart disease were enrolled. Of these, 82 (64.6%) had no PAH, 19 (15%) had mild PAH and 26 (20.4%) had severe PAH. The offspring of women with severe PAH had a higher risk of preterm delivery, low birth weight, neonatal respiratory distress syndrome (NRDS), neonatal intensive care unit (NICU) admission and recurrence of congenital heart disease (CHD). Compared to the women without PAH, only the risk of preterm delivery (32-36 weeks) and NICU admission were slightly higher in mothers with mild PAH; other neonatal events were similar. Multivariate regression analyses showed that the risk of preterm delivery (<37 weeks) increased with the increasing severity of maternal PAH, with an OR of 3.1 (95% CI, 1.1-8.8) for mild and 21.9 (95%CI, 4.8-99.4) for severe PAH. The same pattern was observed for NICU admission. Mothers with severe PAH were independently associated with low birth weight (OR 13, 95%CI 4.3-39, P < 0.001), NRDS (OR 17.9, 95%CI 5.5-58.9, P < 0.001) and recurrence of CHD (OR 4.47, 95%CI 1.7-11.6, P = 0.002). CONCLUSION: Pregnancy in women with severe PAH can significantly increase the risks of neonatal events. While neonatal outcomes in pregnant women with mild PAH were considered optimistic in the present study, a multidisciplinary management of PAH in pregnancy would be necessary to have consistently good outcomes.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2023) conducted a cohort in Pregnancy with heart disease and pulmonary arterial hypertension (n=127). Severe pulmonary arterial hypertension vs. No pulmonary arterial hypertension was evaluated on Preterm delivery (<37 weeks) (OR 21.9, 95% CI 4.8-99.4). Severe maternal pulmonary arterial hypertension was associated with a markedly increased risk of preterm delivery (<37 weeks) compared to no PAH.
Synapse has enriched 10 related papers. Consider them for comparative context: